Literature DB >> 23565434

Adrenocortical carcinoma: An extremely uncommon entity and the role of Immunohistochemistry in its diagnosis.

G Gogoi1, Manash P Baruah, P Borah, M Borgohain.   

Abstract

Adrenocortcal carcinoma is an extremely uncommon entity with an incidence of two in one millionth population. Here we present a 60 year gentleman with pain in abdomen, nausea, and backache, and weight loss. Contrast enhanced computed tomography (CECT) abdomen revealed a heterogenous well defined mass measuring (15 × 10.3 × 13) cm(3) on the left suprarenal region with central necrosis which extended medially up to the midline. Locally, the growth infiltrated the upper pole of left kidney. Initially, the differential diagnosis included that of renal cell carcinoma arising from upper pole of left kidney involving adrenal gland. The patient underwent left radical nephrectomy and left adrenalectomy. Histological evaluation could not differentiate it from of malignant pheochromocytoma, but immunohistochemistry confirmed it as adrenocortical carcinoma. This case highlights the crucial role of immunohistochemistry in establishing the diagnosis like tumors.

Entities:  

Keywords:  Adremanl mass; adrenocortical carcinoma; pheochromocytoma immunohistochemistry

Year:  2012        PMID: 23565434      PMCID: PMC3603082          DOI: 10.4103/2230-8210.104098

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


  8 in total

1.  The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R.

Authors:  David J Gross; Gabriel Munter; Menachem Bitan; Tali Siegal; Alberto Gabizon; Ronny Weitzen; Ofer Merimsky; Aliza Ackerstein; Asher Salmon; Avishai Sella; Shimon Slavin
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

2.  Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.

Authors:  Alexander Stojadinovic; Ronald A Ghossein; Axel Hoos; Aviram Nissan; David Marshall; Maria Dudas; Carlos Cordon-Cardo; David P Jaques; Murray F Brennan
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

Review 3.  Adrenocortical carcinoma: clinical and laboratory observations.

Authors:  B L Wajchenberg; M A Albergaria Pereira; B B Medonca; A C Latronico; P Campos Carneiro; V A Alves; M C Zerbini; B Liberman; G Carlos Gomes; M A Kirschner
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

4.  Weiss criteria in large adrenocortical tumors: a validation study.

Authors:  Manoj Jain; Shalini Kapoor; Anand Mishra; Sushil Gupta; Amit Agarwal
Journal:  Indian J Pathol Microbiol       Date:  2010 Apr-Jun       Impact factor: 0.740

Review 5.  Clinical review: Adrenocortical carcinoma: clinical update.

Authors:  Bruno Allolio; Martin Fassnacht
Journal:  J Clin Endocrinol Metab       Date:  2006-03-21       Impact factor: 5.958

6.  The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.

Authors:  Paul J Zhang; Elizabeth M Genega; John E Tomaszewski; Teresa L Pasha; Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2003-06       Impact factor: 7.842

7.  A rare case of synchronous adrenocortical carcinoma and renal cell carcinoma.

Authors:  Urmila Majhi; Kanchan M Murhekar; Mahendranath P Reddy; Kathiresan Narayanaswamy
Journal:  Indian J Endocrinol Metab       Date:  2011-07

Review 8.  Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.

Authors:  Hironobu Sasano; Takashi Suzuki; Takuya Moriya
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

  8 in total
  2 in total

1.  Feminizing Adrenocortical Carcinoma Without Gynecomastia.

Authors:  Farida Chentli; Fadila Chabour; Djafer Bouchibane; Nouria Nouar
Journal:  Oman Med J       Date:  2017-07

2.  Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma.

Authors:  Impana Shetty; Sarah Fuller; Margarita Raygada; Maria J Merino; B J Thomas; Brigitte C Widemann; Karlyne M Reilly; Karel Pacak; Jaydira Del Rivero
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.